WallStreetZenWallStreetZen

NASDAQ: ABCL
Abcellera Biologics Inc Stock Forecast, Predictions & Price Target

Analyst price target for ABCL

Based on 4 analysts offering 12 month price targets for Abcellera Biologics Inc.
Min Forecast
$18.00+165.1%
Avg Forecast
$27.00+297.64%
Max Forecast
$32.00+371.28%

Should I buy or sell ABCL stock?

Based on 4 analysts offering ratings for Abcellera Biologics Inc.
Strong Buy
Strong Buy
1 analysts 25%
Buy
3 analysts 75%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ABCL stock forecasts and price targets.

ABCL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Credit Suisse
Bottom 4%
4
BuyMaintains$28.00+312.37%2023-05-05
BMO Capital
Bottom 27%
27
BuyMaintains$32.00+371.28%2023-02-22
SVB Leerink
Bottom 1%
1
BuyMaintains$18.00+165.10%2023-01-06
Goldman Sachs
Bottom 12%
12
Strong BuyInitiates Coverage On$30.00+341.83%2022-12-15

1 of 1

ABCL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ABCL$6.79$27.00+297.64%Strong Buy
IOVA$8.80$20.10+128.41%Strong Buy
VCYT$26.72$32.33+21.01%Strong Buy
VTYX$34.00$60.00+76.47%Strong Buy
ACLX$41.99$48.70+15.98%Strong Buy

Abcellera Biologics Stock Forecast FAQ

Is Abcellera Biologics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: ABCL) stock is to Strong Buy ABCL stock.

Out of 4 analysts, 1 (25%) are recommending ABCL as a Strong Buy, 3 (75%) are recommending ABCL as a Buy, 0 (0%) are recommending ABCL as a Hold, 0 (0%) are recommending ABCL as a Sell, and 0 (0%) are recommending ABCL as a Strong Sell.

If you're new to stock investing, here's how to buy Abcellera Biologics stock.

What is ABCL's Price Target?

According to 4 Wall Street analysts that have issued a 1 year ABCL price target, the average ABCL price target is $27.00, with the highest ABCL stock price forecast at $32.00 and the lowest ABCL stock price forecast at $18.00.

On average, Wall Street analysts predict that Abcellera Biologics's share price could reach $27.00 by May 5, 2024. The average Abcellera Biologics stock price prediction forecasts a potential upside of 297.64% from the current ABCL share price of $6.79.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.